Soleus Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123M | Buy |
6,904,302
+1,382,888
| +25% | +$24.6M | 8.14% | 2 |
|
|
2025
Q1 | $98.4M | Buy |
5,521,414
+2,781,710
| +102% | +$49.6M | 7.08% | 2 |
|
|
2024
Q4 | $81.6M | Buy |
+2,739,704
| New | +$81.6M | 5.13% | 1 |
|
|
2024
Q3 | – | Sell |
-108,900
| Closed | -$1.87M | – | 100 |
|
|
2024
Q2 | $1.87M | Sell |
108,900
-586,859
| -84% | -$10.1M | 0.16% | 81 |
|
|
2024
Q1 | $10.9M | Buy |
695,759
+394,759
| +131% | +$6.17M | 0.81% | 34 |
|
|
2023
Q4 | $4.49M | Sell |
301,000
-43,100
| -13% | -$643K | 0.5% | 47 |
|
|
2023
Q3 | $5.56M | Buy |
344,100
+99,000
| +40% | +$1.6M | 0.51% | 49 |
|
|
2023
Q2 | $10.2M | Buy |
245,100
+115,100
| +89% | +$4.78M | 1.13% | 27 |
|
|
2023
Q1 | $7.82M | Buy |
+130,000
| New | +$7.82M | 0.81% | 34 |
|
|
2022
Q3 | – | Sell |
-13,275
| Closed | -$923K | – | 84 |
|
|
2022
Q2 | $923K | Sell |
13,275
-4,000
| -23% | -$278K | 0.14% | 68 |
|
|
2022
Q1 | $1.43M | Sell |
17,275
-5,000
| -22% | -$414K | 0.18% | 59 |
|
|
2021
Q4 | $1.67M | Sell |
22,275
-5,000
| -18% | -$375K | 0.17% | 54 |
|
|
2021
Q3 | $3.17M | Sell |
27,275
-71,700
| -72% | -$8.33M | 0.49% | 49 |
|
|
2021
Q2 | $22M | Buy |
98,975
+73,650
| +291% | +$16.3M | 3.38% | 7 |
|
|
2021
Q1 | $3.35M | Buy |
25,325
+326
| +1% | +$43.1K | 0.6% | 34 |
|
|
2020
Q4 | $4.33M | Sell |
24,999
-27,378
| -52% | -$4.74M | 0.57% | 21 |
|
|
2020
Q3 | $5.83M | Sell |
52,377
-4,020
| -7% | -$447K | 3.09% | 12 |
|
|
2020
Q2 | $3.34M | Buy |
56,397
+50,800
| +908% | +$3.01M | 1.91% | 17 |
|
|
2020
Q1 | $377K | Buy |
+5,597
| New | +$377K | 0.44% | 36 |
|